Article
Serum proteomics analysis from rheumatoid arthritis patients receiving combination therapy of imrecoxib, total glucosides of paeony and two DMARDs
2022-03-07
Abstract excerpt
<h4>Background: </h4> : Rheumatoid arthritis (RA) is a chronic autoimmune disease. Imrecoxib, disease-modifying anti-rheumatic drugs (DMARDs) and total glucosides of paeony (TGPs) are common clinical therapies for RA. However, the exact mechanism of combination therapy for rheumatoid arthritis is still unclear. This study aims to explore the potential mechanism of this combination therapy for RA. <h4>Methods: </h4...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 19bc56da-5df1-582b-b46f-bb4acfed724f
- DOI
- 10.21203/rs.3.rs-1421264/v1
